[Psoriasis and psoriatic arthritis induced by nivolumab (Opdivo®)].
Département de dermatologie et allergologie, CHRU-Hôpital de Brabois, bâtiment des spécialités médicales Philippe-Canton, rue du Morvan, 54511 Vandœuvre-lès-Nancy, France. Electronic address: jl.schmutz@chru-nancy.fr.
J-L
JL
Schmutz
D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D015535:Arthritis, Psoriatic / Q000139:chemically induced*; D006801:Humans; D000077594:Nivolumab; D011565:Psoriasis / Q000139:chemically induced*
D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D000077594:Nivolumab